Abstract
Introduction
The pathogenic measles virus (MV) causes measles in infants. The MV genome is a nonsegmented negative single-stranded RNA consisting of six genes that encode the nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), hemagglutinin (H), and large (L) proteins. The P gene encodes P protein and the nonstructural V and C proteins. Although the nonstructural V and C proteins of wild type (WT) strains of MV are important in suppressing the host interferon (IFN) response in human cells (Gerlier and Valentin, 2009) , WT strains of MV are less able to suppress type I IFN production in murine cells than in human cells (Shingai et al., 2005) , suggesting that V and C proteins are relatively ineffective suppressors for IFN response in murine cells.
CD46 (also called MCP) was first identified as an MV entry receptor for laboratory-adapted and vaccine strains of MV. CD46 is expressed in all human nucleated cells including epithelial cells (Gerlier and Valentin, 2009 ). In 2000, human CD150, a signaling lymphocyte activation molecule (SLAM), was identified as the second MV entry receptor for all MV strains including WT (Tatsuo et al., 2000) .
Expression of CD150 is restricted to activated lymphocytes, dendritic cells (DCs), and macrophages (Delpeut et al., 2012) , consistent with the lymphotropism of MV. However, the expression pattern of CD150 does not explain why WT strains of MV infect epithelial cells that do not express CD150. Recently, human nectin-4 (also called poliovirus receptor-related 4, PVRL4) was identified as the third entry receptor for WT strains of MV (Mühlebach et al., 2011 , Noyce et al., 2011 . Expression of nectin-4 is restricted to the basolateral surface of epithelial cells (Delpeut et al., 2012) . Thus, laboratory-adapted and vaccine strains of MV use CD46 and CD150 as entry receptors, and WT strains of MV use CD150 and nectin-4. Initial infection with WT stains of MV via CD150 occurs in DCs and alveolar macrophages (AMs) and secondary spreading of MV infection is established in lymphocytes through infected DCs and AMs. Ultimately, MV-infected lymphocytes systemically spread to distal sites including the respiratory tract and then MV infects epithelial cells via nectin-4, resulting in release of MV into the airway lumen of the infected lung (Delpeut et al., 2012) .
C-type lectin DC-SIGN (also called CD209) has an important role for infection of DCs by laboratory-adapted and WT strains of MV (de Witte et al., 2006) , although DC-SIGN is dispensable for MV entry. Both attachment and infection of immature DCs with MV are blocked by DC-SIGN inhibitors, suggesting that DC-SIGN is critical for enhancement of CD46/CD150-mediated infection of DCs (de Witte et al., 2006) . Human CD150 transgenic (Tg) and CD150 knock-in mice were generated as MV infection models to study receptor tropism and the immune dynamics of MV (Hahm et al., 2003 , Hahm et al., 2004 , Ohno et al., 2007 , Sellin et al., 2006 , Shingai et al., 2005 , Welstead et al., 2005 In this review, we summarized the mouse model studies on the host antiviral response to MV infection, which involves both Toll-like receptors (TLRs) and retinoic acid-inducible gene (RIG)-I-like receptors (RLRs) in specific DC subsets.
Type I IFN-inducing pathways respond to viral RNA
The IFN response, which is the induction of type I IFN-/is a major antiviral defense pathway that confers virus resistance to neighboring cells. Previous reports
showed that viral RNA is detected by cytoplasmic pattern recognition receptors ( 2007, Wies et al., 2013) . The CARD domain of RLRs is phosphorylated by unknown kinases in steady state, prohibiting RLR activation (Wies et al., 2013) . Viral infection activates RLRs via dephosphorylation by serine-threonine phosphatases PP1 and PP1 (Wies et al., 2013 RLRs, TLR expression is restricted to particular cell types with a different set of TLRs (Table I ) (Edwards et al., 2003) . This differential expression pattern of TLRs directs specific sets of cells to respond to particular TLR ligands, which enhance a variety of immune responses.
Type I IFN induction in MV-infected murine DCs

Studies in mice with targeted gene deletions provide insight into the mechanisms of type I IFN induction in response to MV infection in vivo and in vitro.
Bone marrow-derived DCs (BMDCs) were used to study MV permissiveness of DCs, initially in CD150Tg mice (Ohno et al., 2007 , Shingai et al., 2005 , Welstead et al., 2005 . Studies using BMDCs from CD150Tg mice in combination with Mavs (Lazear et al., 2013) . For MV, IRF5 might be a transcription factor for MAVS-dependent and IRF3/IRF7-independent type I IFN induction in BMDCs (Figure 2 ). (Table I ) (Edwards et al., 2003 , Luber et al., 2010 . Mouse pDCs express most TLRs except TLR3 and therefore respond to a wide range of pathogen-associated molecular patterns including TLR7 ligand (Boonstra et al., 2003 , Edwards et al., 2003 . CD8 + DCs express high amounts of TLR3, but not TLR7 (Edwards et al., 2003) and mainly participate in poly I:C-induced cross-presentation. In contrast to BMDCs, type I IFN gene expression is observed in DCs and splenocytes derived from MV-infected CD150Tg/Mavs -/-mice, which prevents DCs from MV infection in vivo in these mice (Takaki et al., 2013 (Takaki et al., , 2014 . RIG-I/MAVS but not TLR7/MyD88 mediates the antiviral response to RNA virus in conventional DCs.
The studies using reporter mouse that expresses green fluorescence protein (GFP) under the control of the Ifn-6 promoter show that intranasal infection with newcastle disease virus (NDV) induces GFP expression in AMs and cDCs in lung as an initial defense via the RLR pathway (Kumagai et al., 2007) . Although systemic NDV infection leads to GFP expression in not only pDCs but also cDCs and AMs, the frequency of GFP positive cells is higher in pDCs than in other cells. Thus, the activation of different subsets of DCs would be important to produce type I IFNs in systemic and local RNA virus infection.
Similar to murine DCs, PRRs expression differs with subsets of human DCs (Table I) 
Type I IFN and cytokines in the context of MV immunosuppression
DCs contribute to MV-induced immunosuppression, including downregulation of costimulatory molecules and inhibition of IL-12 production following lipopolysaccharide stimulation (Coughlin et al., 2013 , Hahm et al., 2004 , Hahm et al., 2008 82:12365- TLR2  TLR3  TLR4  TLR5  TLR6  TLR7  TLR8 Type I IFN   IRF7  IRF7  IRF7 NF-kB
